Skip to main content
. 2017 Aug 9;8(39):65699–65716. doi: 10.18632/oncotarget.20081

Figure 7. Prognostic power of epigenetic subgroups for the validation cohort.

Figure 7

Progression free survival (PFS) (A) and treatment free survival (TFS) (B) Kaplan-Meier curves are depicted for the 3 cytosine derivative subgroups (Global: n = 22; Partial: n = 26; Normal: n = 8) in the validation cohort. Statistical differences between the curves were calculated using the log-rank test.